In vitro activities of antimicrobial cationic peptides; melittin and nisin, alone or in combination with antibiotics against Gram-positive bacteria

References

• Rosenthal VD, Maki DG, Mehta A, Alvarez-Moreno C, Leblebicioglu H, Higuera F, et al.. International Nosocomial Infection Control Consortium report, data summary for 2002–2007, issued January 2008. Am J Infect Control. 2008;36(9):627–37.
   PubMed Web of Science ®Google Scholar
• Fluckiger U, Widmer AF. Epidemiology of methicillin-resistant Staphylococcus aureus. Chemotherapy. 1999;45:121–34.
   PubMed Web of Science ®Google Scholar
• Maltezou HC, Giamarellou H. Community-acquired methicillin-resistant Staphylococcus aureus infections. Int J Antimicrob Agents. 2006;27:87–96.
   PubMed Web of Science ®Google Scholar
• Cookson BD, Macrae MB, Barrett SP, Brown DF, Chadwick C, French GL, et al.. Combined Working Party of the Hospital Infection Society and Infection Control Nurses Association. Guidelines for the control of glycopeptide-resistant enterococci in hospitals. J Hosp Infect. 2006;62:6–21.
   PubMed Web of Science ®Google Scholar
• French GL. The continuing crisis in antibiotic resistance. Int J Antimicrob Agents. 2010;36(3):3–7.
   Web of Science ®Google Scholar
• Donadio S, Maffioli S, Monciardini P, Sosio M, Jabes D. Antibiotic discovery in the twenty-first century: current trends and future perspectives. J Antibiot. 2010;63(8):423–30.
   PubMed Web of Science ®Google Scholar
• Hancock RE, Chapple DS. Peptide antibiotics. Antimicrob Agents Chemother. 1999;43(6):1317–23.
   PubMed Web of Science ®Google Scholar
• Raghuraman H, Chattopadyay A. Melittin: a membrane-active peptide with diverse functions. Biosci Rep. 2007;27:189–223.
   PubMed Web of Science ®Google Scholar
• Zendo T, Yoneyama F, Sonomoto K. Lactococcal membrane-permeabilizing antimicrobial peptides. Appl Microbiol Biotechnol. 2010;88:1–9.
   PubMed Web of Science ®Google Scholar
• Bierbaum G, Sahl HG. Lantibiotics: mode of action, biosynthesis and bioengineering. Curr Pharm Biotechnol. 2009,10(1):2–18.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Informational Supplement. 16th ed. M100-S20. Wayne, PA: CLSI; 2010.
   Google Scholar
• Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Guideline. 7th ed. M7-A7. Wayne, PA: CLSI; 2006.
   Google Scholar
• Giacometti A, Cirioni O, Barchiesi F, Del Prete MS, Fortuna M, Caselli F, et al.. In vitro susceptibility tests for cationic peptides: comparison of broth microdilution methods for bacteria that grow aerobically. Antimicrob Agents Chemother. 2000;44(6):1694–6.
   PubMed Web of Science ®Google Scholar
• Steinberg DA, Hurst MA, Fujii CA, Kung AH, Ho JF, Cheng FC, et al.. Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob Agents Chemother. 1997;41(8):1738–42.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Methods for Determining Bactericidal Activity of Antimicrobial Agents. Approved Guideline. M26-A. Wayne, PA: NCCLS; 1999.
   Google Scholar
• Pillai SK, Moellering RC, Eliopoulos GM. Antimicrobial Combinations. In: , Lorian V, ed, editor. Antibiotics in laboratory medicine. 5th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2005.
   Google Scholar
• Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 2003;52:1.
   PubMed Web of Science ®Google Scholar
• Wiesnar J, Vilcinskas A. Antimicrobial peptides: the ancient arm of the human immune system. Virulence. 2010;1(5):440–64.
   PubMed Web of Science ®Google Scholar
• Hancock RE, Sahl HG. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol. 2006;24:1551–7.
   PubMed Web of Science ®Google Scholar
• Brumfitt W, Salton MR, Hamilton-Miller JM. Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. J Antimicrob Chemother. 2002;50(5):731–4.
   PubMed Web of Science ®Google Scholar
• Piper C, Draper LA, Cotter PD, Ross RP, Hill C. A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species. J Antimicrob Chemother. 2009;64(3):546–51.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Nisin preparation: affirmation of GRAS status as a direct human food ingredient. Fed Regist. 1988;53:11247–51.
   Google Scholar
• Cleveland J, Montville TJ, Nes IF, Chikindas MOL. Bacteriocins: safe, natural antimicrobials for food preservation. Int J Food Microbiol. 2001;71:1–20.
   PubMed Web of Science ®Google Scholar
• Kramer NE, Smid EJ, Kok J, de Kruijff B, Kuipers OP, Breukink E. Resistance of gram-positive bacteria to nisin is not determined by lipid II levels. FEMS Microbiol Lett. 2004;239:157–61.
   PubMed Web of Science ®Google Scholar
• Cao Y, Yu RQ, Liu Y, Zhou HX, Song LL, Cao Y, et al.. Design, recombinant expression, and antibacterial activity of the cecropins–melittin hybrid antimicrobial peptides. Curr Microbiol. 2010;61(3):169–75.
   PubMed Web of Science ®Google Scholar
• Yeaman MR, Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev. 2003;55:27–55.
   PubMed Web of Science ®Google Scholar
• Giacometti A, Cirioni O, Kamysz W, D’Amato G, Silvestri C, Simona Del Prete M, et al.. In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1–7) M(2–9)NH2 on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics. Diagn Microbiol Infect Dis. 2004;49(3):197–200.
   PubMed Web of Science ®Google Scholar